General description
Plazomicin is a next-generation aminoglycoside ("neoglycoside") used in the treatment of multi-drug resistant infections caused by carbapenem resistant Enterobacteriaceae, carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii.
INN
Plazomicin
ATC codes
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 2019
(TRS
1021)
for
Carbapenem resistant Enterobacterales
Added in 2019
(TRS
1021)
for
Carbapenem-resistant Pseudomonas aeruginosa
Added in 2019
(TRS
1021)
for
Carbapenem resistant Acinetobacter baumannii
Wikipedia
DrugBank
Recommendations
Section
Reserve group antibiotics
- Parenteral > General injections > IV: 500 mg per 10 mL